ImmuCell Corporation is a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries. The Company develops, manufactures and markets the First Defense® product line that provides “immediate immunity” against aggressive pathogens, including E. coli and coronavirus, in newborn dairy and beef calves without the use of traditional antibiotics. This reduces the amount of antibiotics in the human food chain and it maximizes the productive capabilities of dairy and beef producers future operating assets – their newborn calves.
The Company is in the late stages of developing a novel purified Nisin intramammary treatment that addresses subclinical mastitis in fully grown milking cows. Mastitis is the most significant cause of economic loss to the dairy industry totaling approximately $2 BILLION annually. Our product will treat infections in milk producing cows without the use of traditional antibiotics, and reduces the amount of antibiotics in the milk supply.